Physician profile
Tejinder S Mander
NPI 1740265701
$15,067.80
in general payments reported to CMS, 2019-2025
53 companies · $2,314 in 2025
The $2,314 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,522 · 2020: $1,652 · 2021: $1,967 · 2022: $2,646 · 2023: $2,120 · 2024: $1,847 · 2025: $2,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,166 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,166.24 |
| Education | $115.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,490.13 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $1,380.62 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $1,333.06 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,158.00 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,032.37 | 2019-2025 | Brilinta, Andexxa, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $860.61 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $673.99 | 2019-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $650.36 | 2021-2025 | |
| Amarin Pharma, INC. | $629.08 | 2019-2022 | |
| Pfizer INC. | $596.89 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $544.86 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $493.74 | 2021-2025 | Verquvo, Winrevair |
| Actelion Pharmaceuticals US, INC. | $431.60 | 2021-2025 | Opsumit, Uptravi |
| Alnylam Pharmaceuticals INC. | $420.17 | 2022-2025 | Onpattro, Amvuttra |
| Boston Scientific Corporation | $398.82 | 2019-2025 | General - Therapies, Avvigo Guidance System, Rotapro |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $387.82 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $321.03 | 2019-2024 | Cardiomems |
| Chiesi USA, INC. | $212.79 | 2019-2025 | Cleviprex, Kengreal |
| Kiniksa Pharmaceuticals, LTD. | $210.53 | 2021-2023 | Arcalyst |
| Daiichi Sankyo INC. | $167.02 | 2019-2024 | Injectafer |
| Esperion Therapeutics, INC. | $166.67 | 2020-2025 | Nexletol |
| Astellas Pharma US INC | $120.02 | 2021 | |
| Irhythm Technologies, INC. | $100.85 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $99.13 | 2019-2023 | |
| Lundbeck LLC | $95.04 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $93.03 | 2024 | Arcalyst |
| Csl Behring | $89.60 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $81.59 | 2019 | |
| Vital Connect, INC | $66.26 | 2024 | Vitalpatch Rtm |
| Bridgebio Pharma, INC. | $62.91 | 2025 | Attruby |
| Bardy Diagnostics, INC. | $60.01 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $53.60 | 2020-2023 | Livalo |
| Lilly USA, LLC | $47.88 | 2025 | Zepbound, Mounjaro |
| Xeris Pharmaceuticals, INC. | $45.15 | 2025 | Keveyis |
| Hologic INC | $44.40 | 2022 | |
| Medtronic Vascular, INC. | $39.93 | 2020 | |
| Impulse Dynamics (USA) INC. | $39.21 | 2023-2024 | Optimizer, Optimizer |
| Atricure, INC. | $38.79 | 2022 | |
| Janssen Biotech, INC. | $34.00 | 2019 | |
| Baxter Healthcare | $32.45 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $30.31 | 2023 | Inpefa |
| Dexcom, INC. | $29.01 | 2025 | Dexcom G6 Transmitter |
| Kestra Medical Technology Services, INC. | $28.14 | 2024 | Assure Wcd |
| Alexion Pharmaceuticals, INC. | $23.07 | 2021 | |
| Biotronik INC. | $20.99 | 2025 | |
| Abiomed | $20.58 | 2025 | |
| Elutia, INC. | $20.16 | 2021 | |
| Genzyme Corporation | $19.13 | 2025 | |
| Amryt Pharma Holdings LTD | $16.88 | 2021 | |
| Scpharmaceuticals INC. | $15.07 | 2025 | |
| Medtronic USA, INC. | $14.13 | 2020 | |
| Bsn Medical INC | $13.38 | 2020 | |
| Philips North America LLC | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejinder Mander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.